Grant funding up to $2.4M for U.S. startups and small businesses to advance research, development and commercialization of health-related innovations including drugs, medical devices and digital health.
We are experts in securing non-dilutive funding from US federal and European Commission funding programs, providing you with the capital to execute your vision.
Alien works as a strategic partner to enterprises focused on deep-tech innovation. Our mission is to provide business leaders with the resources to commercialize market-disrupting solutions.
We guide you through the complex public funding landscape and provide assistance throughout the entire innovation project. Our integrated, end-to-end service ensures that your innovation receives the financial backing and strategic guidance needed to achieve commercial success.
Grant funding up to $2.4M for U.S. startups and small businesses to advance research, development and commercialization of health-related innovations including drugs, medical devices and digital health.
Grant funding up to $2.5M+ for universities, research institutions, public or private, and non-profit or for-profit organizations. NIH’s most established mechanism for high-impact and well-defined, investigator-initiated health-related research projects across all scientific stages.
Grant funding up to $275,000 for universities, research institutions, hospitals, and
small businesses and startups to support high-risk, high-reward exploratory and pilot studies that generate innovative ideas or critical preliminary data for future large-scale research.
Grant funding up to $1.6M for U.S. startups and small businesses to transform advanced science and engineering innovations into market-ready products.
Grant funding up to $1.85M for U.S. startups and small businesses for high-impact R&D in energy, environment, and national security, with options for both SBIR and STTR programs depending on collaboration needs.
Payments up to €400,000 are available to companies in NATO member countries, supporting the development of dual-use deep-tech innovation.
Grant funding up to €4 million for early-stage research teams, including startups and SMEs and research organizations in the EU and Horizon Europe Associated Countries to advance ambitious scientific projects with the potential to create new markets.
Grant funding up to €2.5 million for startups, SMEs, and research organizations in the EU and Horizon Europe Associated Countries to
turn results from projects funded under EIC Pathfinder, ERC Proof of Concept, EDF and eligible RIAs into validated prototypes, supporting their path towards commercialization.
Grant funding up to €2.5M and equity funding up to €10M for start-ups & SMEs from the EU andHorizon Europe Associated Countries to commercialize innovations.
Connect with us now to know how we can help you raise funds on a no-win no-fee basis.
Portfolio of services uniquely designed and offered on a no-win no-fee basis to support high-risk companies in attracting public funding and private investment.
Specialized grant management and accounting to ensure compliance, accuracy and effective use of funding.
Comprehensive regulatory strategy and implementation to guide you through the complex and ever-evolving landscapes of medical devices and pharmaceuticals.
Intellectual property strategy development and protection services, empowering you to maximize the value of your innovation.
Real feedback from the innovators, founders, and researchers we've helped secure funding and navigate complex grant processes.
